QSAR modeling of the interaction of flavonoids with GABA(A) receptor.

[1]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[2]  G. Webb,et al.  Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones. , 1977, Journal of medicinal chemistry.

[3]  Danail Bonchev,et al.  Information theoretic indices for characterization of chemical structures , 1983 .

[4]  J. Phillis,et al.  The role of adenosine in the central actions of the benzodiazepines , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  J. Bormann.  Electrophysiology of GABAA and GABAB receptor subtypes , 1988, Trends in Neurosciences.

[6]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.

[7]  J H Medina,et al.  Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. , 1990, Biochemical pharmacology.

[8]  P. Skolnick,et al.  The agonist pharmacophore of the benzodiazepine receptor. Synthesis of a selective anticonvulsant/anxiolytic. , 1991, Journal of medicinal chemistry.

[9]  J. Woods,et al.  Benzodiazepines: use, abuse, and consequences. , 1992, Pharmacological reviews.

[10]  Ettore Novellino,et al.  Study of Benzodiazepines Receptor Sites Using a Combined QSAR‐CoMFA Approach , 1992 .

[11]  Hxugo Kubiny.  Variable Selection in QSAR Studies. I. An Evolutionary Algorithm , 1994 .

[12]  R. Olsen,et al.  GABAA receptor channels. , 1994, Annual review of neuroscience.

[13]  H. Kubinyi.  Variable Selection in QSAR Studies. II. A Highly Efficient Combination of Systematic Search and Evolution , 1994 .

[14]  Han van de Waterbeemd,et al.  Chemometric methods in molecular design , 1995 .

[15]  F. Stephenson,et al.  The GABAA receptors. , 1995, The Biochemical journal.

[16]  H. Viola,et al.  6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. , 1996, Biochemical and biophysical research communications.

[17]  M Karplus,et al.  Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. , 1996, Journal of medicinal chemistry.

[18]  E. Novellino,et al.  Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor. , 1996, Journal of medicinal chemistry.

[19]  Satya P. Gupta,et al.  Quantitative Structure ‐ Activity Relationship Studies on Benzodiazepine Receptor Binding of Some Nonbenzodiazepine Series of Ligands , 1996 .

[20]  J. Medina,et al.  Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor , 1997 .

[21]  P. Skolnick,et al.  Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors. , 1998, Journal of medicinal chemistry.

[22]  J H Medina,et al.  Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. , 1998, Biochemical and biophysical research communications.

[23]  T. Liljefors,et al.  Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. , 1999, Journal of medicinal chemistry.

[24]  D. Nutt,et al.  The use of benzodiazepines in anxiety and other disorders , 1998, European Neuropsychopharmacology.

[25]  G. Pei,et al.  3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. , 2001, Journal of medicinal chemistry.

[26]  J H Medina,et al.  Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex. , 2001, Bioorganic & medicinal chemistry.

[27]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[28]  Paola Gramatica,et al.  Structure/Response Correlations and Similarity/Diversity Analysis by GETAWAY Descriptors, 2. Application of the Novel 3D Molecular Descriptors to QSAR/QSPR Studies , 2002, J. Chem. Inf. Comput. Sci..

[29]  T. Liljefors,et al.  Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor. , 2002, Journal of medicinal chemistry.

[30]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[31]  Douglas M. Hawkins,et al.  Assessing Model Fit by Cross-Validation , 2003, J. Chem. Inf. Comput. Sci..

[32]  Anton J. Hopfinger,et al.  3D-Pharmacophores of Flavonoid Binding at the Benzodiazepine GABAA Receptor Site Using 4D-QSAR Analysis , 2003, J. Chem. Inf. Comput. Sci..

[33]  H. Xue,et al.  Naturally occurring 2'-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. , 2003, Biochemical pharmacology.

[34]  J. Medina,et al.  Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands , 1997, Neurochemical Research.

[35]  Rajni Garg,et al.  Comparative quantitative structure-activity relationship studies (QSAR) on non-benzodiazepine compounds binding to benzodiazepine receptor (BzR). , 2004, Chemical reviews.

[36]  Maykel Pérez González,et al.  A new search algorithm for QSPR/QSAR theories: Normal boiling points of some organic molecules , 2005 .

[37]  J. Paysan,et al.  Heterogeneity of GABAA-receptors: cell-specific expression, pharmacology, and regulation , 1995, Neurochemical Research.

[38]  Maykel Pérez González,et al.  Application of the replacement method as a novel variable selection strategy in QSAR. 1. Carcinogenic potential , 2006 .

[39]  M. Fernández,et al.  QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Bioorganic & medicinal chemistry.

[40]  Patricia Vázquez,et al.  SYNTHESIS OF SUBSTITUTED FLAVONES AND ARYLCHROMONES USING Ρ AND Si KEGGIN HETEROPOLYACIDS AS CATALYSTS , 2007 .